The rising tide of polypharmacy and drug-drug interactions: Population database analysis 1995-2010

BMC Medicine

Volumn 13, Issue 1, 2015, Pages

  Guthrie, Bruce ^a   Makubate, Boikanyo ^b   Hernandez Santiago, Virginia ^a   Dreischulte, Tobias ^c  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b UNIVERSITY OF BOTSWANA   (Botswana)

^c NHS TAYSIDE   (United Kingdom)

Author keywords

Drug interactions; Family practice; Physician; Polypharmacy; Prescribing patterns; Primary care

Indexed keywords

AGENTS ACTING ON THE AUDITORY AND VESTIBULAR SYSTEMS; AGENTS ACTING ON THE EYE; AGENTS ACTING ON THE PERIPHERAL NERVOUS AND NEUROMUSCULAR SYSTEMS; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; CARDIOVASCULAR AGENT; CENTRAL NERVOUS SYSTEM AGENTS; DERMATOLOGICAL AGENT; GASTROINTESTINAL AGENT; HORMONE; IMMUNOSUPPRESSIVE AGENT; PARENTERAL SOLUTION; RESPIRATORY TRACT AGENT; URINARY TRACT AGENT;

ADULT; AGE; AGED; ARTICLE; CLINICAL PRACTICE; CLUSTER ANALYSIS; CROSS-SECTIONAL STUDY; DRUG INTERACTION; DRUG USE; FEMALE; HOME CARE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; POLYPHARMACY; PRESCRIPTION; PRIMARY MEDICAL CARE; QUALITY OF LIFE; SEX RATIO; SOCIAL STATUS; UNITED KINGDOM; VERY ELDERLY; YOUNG ADULT; DEMOGRAPHY; FACTUAL DATABASE; PRIMARY HEALTH CARE; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA;

ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DATABASES, FACTUAL; DRUG INTERACTIONS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; POLYPHARMACY; PRACTICE PATTERNS, PHYSICIANS'; PRIMARY HEALTH CARE; QUALITY OF LIFE; RESIDENCE CHARACTERISTICS; SCOTLAND; YOUNG ADULT;

EID: 84928645829     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/s12916-015-0322-7     Document Type: Article

References (28)

1. Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18,820 patients. BMJ. 2004;329:15-9.
2. Howard R, Avery A, Slavenburg S, Royal S, Pipe G, Lucassen P, et al. Which drugs cause preventable admissions to hospital? A systematic review. Br J Clin Pharmacol. 2007;63:136-47.
3. Burgess C, Holman C, Satti A. Adverse drug reactions in older Australians, 1981-2002. Med J Aust. 2005;182:267-70.
4. Bourgeois FT, Shannon MW, Valim C, Mandl KD. Adverse drug events in the outpatient setting: an 11-year national analysis. Pharmacoepidemiol Drug Saf. 2010;19:901-10.
5. Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012;380:37-43.
6. Shah BM, Hajjar ER. Polypharmacy, adverse drug reactions, and geriatric syndromes. Clin Geriatr Med. 2012;28:173-86.
7. Gandhi TK, Weingart SN, Borus J, Seger AC, Peterson J, Burdick E, et al. Adverse drug events in ambulatory care. N Engl J Med. 2003;348:1556-64.
8. Johnell K, Klarin I. The relationship between number of drugs and potential drug-drug interactions in the elderly: a study of over 600,000 elderly patients from the Swedish prescribed drug register. Drug Saf. 2007;30:911-8.
9. Haider S, Johnell K, Thorslund M, Fastbom J. Trends in polypharmacy and potential drug-drug interactions across educational groups in elderly patients in Sweden for the period 1992-2002. Int J Clin Pharmacol Ther. 2007;45:643-53.
10. Aronson J. Polypharmacy, appropriate and inappropriate. Br J Gen Pract. 2006;56:484-5.
11. Steinman MA, Hanlon JT. Managing medications in clinically complex elders. JAMA. 2010;304:1592-601.
12. Van Spall HGC, Toren A, Kiss A, Fowler RA. Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review. JAMA. 2007;297:1233-40.
13. Masoudi FA, Havranek EP, Wolfe P, Gross CP, Rathore SS, Steiner JF, et al. Most hospitalized older persons do not meet the enrollment criteria for clinical trials in heart failure. Am Heart J. 2003;146:250-7.
14. Travers J, Marsh S, Caldwell B, Williams M, Aldington S, Weatherall M, et al. External validity of randomized controlled trials in COPD. Respir Med. 2007;101:1313-20.
15. Saunders C, Byrne CD, Guthrie B, Lindsay RS, McKnight JA, Philip S, et al. External validity of randomized controlled trials of glycaemic control and vascular disease: how representative are participants? Diabet Med. 2013;30:300-8.
16. Hughes L, McMurdo MET, Guthrie B. Guidelines for people not for diseases: the challenges of applying UK clinical guidelines to people with multimorbidity. Age Ageing. 2013;42:62-9.
17. Guthrie B, Payne K, Alderson P, McMurdo MET, Mercer SW. Adapting clinical guidelines to take account of multimorbidity. BMJ. 2012;345:e6341.
18. Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases. JAMA. 2005;294:716-24.
19. Nobili A, Pasina L, Tettamanti M, Lucca U, Riva E, Marzona I, et al. Potentially severe drug interactions in elderly outpatients: results of an observational study of an administrative prescription database. J Clin Pharm Ther. 2009;34:377-86.
20. Obreli Neto PR, Nobili A, Marusic S, Pilger D, Guidoni CM, Baldoni Ade O, et al. Prevalence and predictors of potential drug-drug interactions in the elderly: a cross-sectional study in the Brazilian primary public health system. J Pharm Pharm Sci. 2011;15:344-54.
21. Lin C-F, Wang C-Y, Bai C-H. Polypharmacy, aging and potential drug-drug interactions in outpatients in Taiwan: a retrospective computerized screening study. Drugs Aging. 2011;28:219-25.
22. Guthrie B, McCowan C, Davey P, Simpson CR, Dreischulte T, Barnett K. High risk prescribing in primary care patients particularly vulnerable to adverse drug events: cross sectional population database analysis in Scottish general practice. BMJ. 2011;342:d3514.
23. Office of the Chief Statistician. Scottish Index of Multiple Deprivation 2004 Summary Technical Report. Edinburgh: Scottish Executive; 2004.
24. Fincke B, Snyder K, Cantillon C, Gaehde S, Standring P, Fiore L, et al. Three complementary definitions of polypharmacy: methods, application and comparison of findings in a large prescription database. Pharmacoepidemiol Drug Saf. 2005;14:121-8.
25. British Medical Association, Royal Pharmaceutical Society. British National Formulary 59 (March 2010). London: BMJ Group and Pharmaceutical Press, London; 2010.
26. Franchi C, Tettamanti M, Pasina L, Djignefa C, Fortino I, Bortolotti A, et al. Changes in drug prescribing to Italian community-dwelling elderly people: the EPIFARM-Elderly Project 2000-2010. Eur J Clin Pharmacol. 2014;70:437-43.
27. MHRA. Simvastatin: updated advice on drug interactions - updated contraindications. Drug Safety Update. 2012;6:S1.
28. Patterson S, Hughes C, Kerse N, Caldwell C, Bradley M. Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev. 2012;5:CD008165.